Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT07168499
- Status
- Recruiting
Conditions
- IBD (Inflammatory Bowel Disease)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Diet Management — BEHAVIORALVisit with IBD dietician for diet management specifically for IBD
- Stress Management — BEHAVIORALVisit with IBD GI psychologist for stress management
Study Details
Inflammatory Bowel Disease (IBD), which includes Crohn's Disease (CD) and Ulcerative Colitis (UC), is a chronic, immune-mediated disease characterized by recurrent episodes of relapse. The goal of this single site, pragmatic, randomized trial is to answer if combining lifestyle modifications (mindfulness/stress management + nutrition support) with advanced therapies for induction and maintenance of clinical remission in CD and UC as evaluated by disease activity scores in patients with active CD and UC. Researchers will compare 4 study arms (Group 1, Group 2, Group 3, and Group 4) to see if combining lifestyle modifications with advanced therapies for induction and maintenance will show improvement in condition as evaluated by disease activity scores. Groups: 1. Group A - Subjects will receive a visit with an IBD dietician and a visit with an IBD GI psychologist within the first month of advanced therapy initiation and another visit with both parties 4+/-2 weeks after the first intervention visit. 2. Group B - Subjects will receive a visit with an IBD dietician within the first month of advanced therapy initiation and another visit 4+/-2 weeks after the first intervention visit. They will later be offered a visit with an IBD GI psychologist after 3 months (after assessment of our primary outcomes). 3. Group C - Subjects will receive a visit with an IBD psychologist within the first month of advanced therapy initiation and another visit with the IBD GI psychologist 4+/-2 weeks after the first intervention visit. They will later be offered a visit with an IBD dietician after 2 months (after assessment of our primary outcomes). 4. Group D - Subjects will be offered a visit with an IBD GI psychologist and IBD dietician after 3 months (after assessment of our primary outcomes). All subjects will be asked to complete a set of questionnaires and have the option to give blood and stool samples throughout the life of their participation in the study at certain visits.
Key Dates
- Start date
- Sep 15, 2025
- Status verified
- Nov 2025
- Primary completion
- May 1, 2027
- Completion
- May 1, 2028
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Group A - Combined diet + stress managementSubjects will receive a visit with an IBD dietician and a visit with an IBD GI psychologist (whether in person or virtual) within the first month of advanced therapy initiation and another visit with each of the IBD dietician and the IBD GI psychologist 4+/- 2 weeks after first intervention visit.
- Active Comparator: Group B - Diet AloneSubjects will receive a visit with an IBD dietician (whether in person or virtual) within the first month of advanced therapy initiation and another visit with the IBD dietician 4+/-2 weeks after first intervention visit. They will be later offered a visit with an IBD GI psychologist after 3 months (after assessment of our primary outcomes).
- Active Comparator: Group C - Stress management aloneSubjects will receive a visit with an IBD GI psychologist (whether in person or virtual) within the first month of advanced therapy initiation and another visit with the IBD GI psychologist 4+/-2 weeks after first intervention visit. They will be later offered a visit with an IBD dietician after 3 months (after assessment of our primary outcomes).
- No Intervention: Group D - Usual Care ArmSubjects will be offered a visit with an IBD GI psychologist and IBD dietician (whether in person or virtual) after 3 months (after assessment of our outcomes).
Primary Outcome Measure
Change marked by clinical remission of IBD [ Time Frame: 12 weeks, 24 weeks ]
Central Contacts
- Emily A Nolan, DNP, MS, BA, PMHNP-BC, RN617-724-7559
- Aarushi Gupta
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Aarushi Gupta Ashwin Ananthakrishnan, MD, MPH (PRINCIPAL_INVESTIGATOR) Maryam Ibrahim (SUB_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBDNot Yet Recruiting · Cook Children's Health Care System · Arlington, Texas
- Evaluation of the SMART IBD App in Pediatric IBDRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.Enrolling By Invitation · DiaSorin Inc. · Minneapolis, Minnesota